Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sullivan, V.
Right arrow Articles by Kelly, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sullivan, V.
Right arrow Articles by Kelly, R. F.
(Chest. 2005;128:2671-2676.)
© 2005 American College of Chest Physicians

Advanced Age Does Not Exclude Lobectomy for Non-small Cell Lung Carcinoma*

Vita Sullivan, MD; Tao Tran, MD; Amy Holmstrom, RN; Michael Kuskowski, PhD; Paul Koh, MD; Jeffrey B. Rubins, MD, FCCP and Rosemary F. Kelly, MD, FCCP

* From the Division of Cardiovascular and Thoracic Surgery (Drs. Sullivan, Tran, Koh, and Kelly), University of Minnesota, Minneapolis, MN; and the Departments of Research (Ms. Holmstrom), Geriatric Research (Dr. Kuskowski), and Medicine (Dr. Rubins), Education & Clinical Center, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN.

Correspondence to: Rosemary F. Kelly, MD, Minneapolis VA Medical Center (112) One Veterans Dr, Minneapolis, MN 55417; e-mail: kelly071{at}umn.edu

Study objectives: Localized non-small cell lung carcinoma (NSCLC) is best treated by complete surgical resection, commonly requiring lobectomy. The impact of lobectomy on the health status of the elderly patient is not well-characterized. The aim of this study was to compare the effect of lobectomy in elderly patients (≥ 70 years of age) and younger patients (< 70 years of age) on their pulmonary function and functional status 1 year following surgery.

Design: One hundred forty patients underwent lobectomy for NSCLC at the Minneapolis Veterans Affairs Medical Center from January 1999 to December 2003. All patients underwent pulmonary function tests (PFTs) and functional status assessment using Karnofsky scores (KS) that were assessed preoperatively. Sixty-three of 140 lobectomy patients were available 1 year postoperatively for reevaluation by PFTs and KS.

Results: There was no statistical difference between groups in either the pulmonary function or functional status testing results at 1 year after undergoing lobectomy. FVC decreased by 14% in the elderly patient and by 9% in the younger patient group. FEV1 decreased by 19% in elderly patients and by 13% in younger patients. Functional status declined for two older patients (8%), who dropped their KS from 80 to 100% (normal activity without limitation) to 40 to 70% (unable to work, but able to care of self at home). Nine of the younger patients (24%) had KS drop from 80 to 100% to 40 to 70%. There was one perioperative death (30-day mortality rate for the study groups, 1.5%).

Conclusions: Elderly patients ≥ 70 years of age undergoing lobectomy for NSCLC had similar PFT results and functional status as younger patients < 70 years of age 1 year after undergoing surgery. Curative resection should not be denied based on age alone.

Key Words: elderly • lobectomy • Karnofsky score • non-small cell lung carcinoma • pulmonary function tests • surgery






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.